Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019

SELL
$19.43 - $26.41 $10,200 - $13,865
-525 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$18.19 - $31.79 $3,547 - $6,199
-195 Reduced 27.08%
525 $12,000
Q3 2018

Nov 14, 2018

SELL
$27.65 - $38.39 $10,368 - $14,396
-375 Reduced 34.25%
720 $23,000
Q1 2018

May 11, 2018

SELL
$29.84 - $44.08 $3,580 - $5,289
-120 Reduced 9.88%
1,095 $36,000
Q4 2017

Feb 02, 2018

BUY
$21.89 - $31.34 $13,352 - $19,117
610 Added 100.83%
1,215 $37,000
Q3 2017

Dec 13, 2017

SELL
$15.81 - $24.01 $307,472 - $466,946
-19,448 Reduced 96.98%
605 $15,000
Q3 2017

Nov 14, 2017

BUY
$15.81 - $24.01 $317,037 - $481,472
20,053
20,053 $15,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $107M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Patten Group, Inc. Portfolio

Follow Patten Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.